金币
UID176556
帖子
主题
积分25187
注册时间2014-6-6
最后登录1970-1-1
听众
性别保密
|
欢迎您注册蒲公英
您需要 登录 才可以下载或查看,没有帐号?立即注册
x
曾了解有生产工艺对质量授权人和QA保密的公司。此种情况下,最终质量受权人如何有效的对产品放行呢???
下文选自EU GMP《Annex 16: Certification by a Qualified Person and Batch Release 》
The purpose of controlling batch release is notably to ensure that:
i. The batch has been manufactured and checked in accordance with the requirements of its MA.
ii. The batch has been manufactured and checked in accordance with the principles and guidelines of GMP.
iii. Any other relevant legal requirements are taken into account.
iv. In the event that a quality defect as referred to in Chapter 8 of EudraLex, Volume 4, Part I, needs to be investigated or a batch recalled, to ensure that any QPs involved in the certification or confirmationand any relevant records are readily identifiable.
1.4. For manufacturing steps performed at sites in the EU each manufacturing site must have at least one QP.
1.4.1 Where the site only undertakes partial manufacturing operations in relation to a batch, then a QP at that site must at least confirm that the operations undertaken by the site have been performed in accordance with GMP and the terms of the written agreement detailing the operations for which the site is responsible. If the QP is responsible for providing confirmation of compliance for those operations with the relevant MA, then the QP should have access to the necessary details of the MA(这个是针对于有partial steps外包的情况,相应的负责该部分的QP不一定需要了解MA,关于MA的符合性问题可以由finished medicine QP进行).
1.4.2 The QP who performs certification of the finished product batch may assume full responsibility for all stages of manufacture of the batch or this
responsibility may be shared with other QPs who have provided confirmation for specified steps in the manufacture and control of a batch. These could be other QPs who are operating under the same manufacturing authorisation (MIA) holder or QPs operating under different MIA holders.
1.4.3 Any sharing of responsibilities amongst QPs in relation to compliance of a batch must be defined in a document formally agreed by all parties. This document should detail responsibility for assessment of the impact any deviation(s) has/have on compliance of the batch with GMP and the MA.
|
|